Texas A&M Football Recruiting

Three Things: A&M hosts Junior Day, All-American Bowl standouts & more

As he does every Friday morning, TexAgs' senior recruiting analyst Jason Howell offered up another round of his weekly recruiting thoughts. In this edition of his three things, Howell offered his thoughts on Junior Day in Aggieland, the Navy All-American Bowl and more.
By Jason Howell
January 10, 2025
6.4k Views
Discuss
Story Poster

1. A&M’s Junior Day

  • Texas A&M will host three commits, two five-star offensive tackles, the state’s No. 1 2026 prospect, two stud 2027 running backs and a couple of 2027 defensive linemen with high-end potential who already hold offers. Overall, it’s a small group with some top-priority targets in 2026 and 2027. There are plenty of reasons to be excited about Saturday’s Junior Day in College Station.
To continue reading, you must be a TexAgs Premium subscriber.
Try Premium for $1
See Subscription Benefits →
Trial only available to users who have never subscribed or participated in a previous trial
Discuss
Tags
Mike Elko Junior Day Three Things All-American Bowl Navy All-American Bowl Lamont Rogers Noah Mikhail Kaydon Finley Kiotti Armstrong Jackson Cantwell Davian Groce Darryus McKinley
Show All
Marco Jones Aaron Gregory Adonyss Currie Nicolas Robertson Dorian Barney Jordan Carter Chace Sims Immanuel Iheanacho Trason Haley Bralan Womack Brayden Spinks Jayden Mack Kaeden Scott Keytrin Harris Xavier Tiller Chase Hancock Seth Tillman Football Recruiting Texas A&M 2025 2026 2027 2028
SPONSORED BY
Hudson Oaks
More Football Recruiting
See All →
Highlights : Richmond Randle remains unbeaten by defeating Iowa Colony
By Cade Draughon
Highlights: Allen beats North Crowley in heavyweight battle in Denton
By Jason Howell
Landen Williams-Callis remains focused on winning another state title
By Cade Draughon
Highlights: South Oak Cliff blanks Port Neches-Groves to move on
By Ryan Brauninger
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.